Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 96.25
+0.16 (0.17%)
Aug 8, 2025, 3:29 PM IST
Chimerix Market Cap
Alpa Laboratories has a market cap or net worth of 2.03 billion as of August 8, 2025. Its market cap has increased by 6.01% in one year.
Market Cap
2.03B
Enterprise Value
898.31M
Revenue
1.12B
Ranking
n/a
PE Ratio
10.31
Stock Price
$96.25
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 2.03B, an increase of 75.64%. That is a compound annual growth rate of 3.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 2.03B | -18.75% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | 760.62M | 113.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.50B |
| Divi's Laboratories | 1,570.11B |
| Cipla | 1,200.16B |
| Apollo Hospitals Enterprise | 1,018.64B |
| Mankind Pharma | 1,018.24B |
| Zydus Lifesciences | 941.99B |
| Fortis Healthcare | 677.46B |
| Aurobindo Pharma | 605.25B |